UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 518

Sortiert nach

Editorial: Rising stars in drugs outcomes research and policies: 2021

Frontiers in pharmacology, 2022-11, Vol.13, p.1076513-1076513

2022

Volltextzugriff (PDF)

Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial

Nephrology, dialysis, transplantation, 2009-02, Vol.24 (2), p.512-518

2009

Volltextzugriff (PDF)

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Circulation (New York, N.Y.), 2005-03, Vol.111 (8), p.1012-1018

2005

Volltextzugriff (PDF)

A randomized n-of-1 study comparing blood pressure measured on a clothed arm and on an arm with a rolled-up sleeve

Acta clinica belgica (English ed. Online), 2023-10, Vol.ahead-of-print (ahead-of-print), p.1-5

Lins, Robert L.

2023

Volltextzugriff (PDF)

Outcome of Acute Kidney Injury with Different Treatment Options: Long-Term Follow-up

Clinical journal of the American Society of Nephrology, 2010-10, Vol.5 (10), p.1755-1762

2010

Volltextzugriff (PDF)

Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury

Critical care (London, England), 2010-01, Vol.14 (6), p.R221-R221

2010

Volltextzugriff (PDF)

RRT treatment for AKI: is more always better?

Nephrology, dialysis, transplantation, 2012-12, Vol.27 (12), p.4252-4255

LINS, Robert L

2012

Volltextzugriff (PDF)

Economic evaluation of different treatment modalities in acute kidney injury

Nephrology, dialysis, transplantation, 2012-11, Vol.27 (11), p.4095-4101

2012

Volltextzugriff (PDF)

Severity scoring and mortality 1 year after acute renal failure

Nephrology, dialysis, transplantation, 2006-04, Vol.21 (4), p.1066-1068

2006

Volltextzugriff (PDF)

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

Nephrology, dialysis, transplantation, 2003-05, Vol.18 (5), p.967-976

2003

Volltextzugriff (PDF)

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

BMJ (Online), 1995-02, Vol.310 (6976), p.358

1995

Volltextzugriff (PDF)

P-624: Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

American journal of hypertension, 2005-05, Vol.18 (S4), p.234A-234A

2005

Volltextzugriff (PDF)

P-204: Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients

American journal of hypertension, 2004-05, Vol.17 (S1), p.108A-108A

2004

Volltextzugriff (PDF)

Problems in the development, validation and adaptation of prognostic models for acute renal failure

Nephrology, dialysis, transplantation, 2001-06, Vol.16 (6), p.1098-1101

2001

Volltextzugriff (PDF)

Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study

Nephrology, dialysis, transplantation, 2004-09, Vol.19 (9), p.2282-2288

2004

Volltextzugriff (PDF)

Treating Hypertensive Patients With Intracranial Pathology

Critical care medicine, 1996-12, Vol.24 (12), p.2072-2072

1996

Volltextzugriff (PDF)

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study

Clinical nephrology, 2004-10, Vol.62 (4), p.287

2004

Volltextzugriff (PDF)

Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at 1-receptor blocker in hypertensive patients

American journal of hypertension, 2004, Vol.17 (5), p.S108-S108

2004

Volltextzugriff (PDF)

Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

American journal of hypertension, 2005-05, Vol.18 (5), p.A234-A234

2005

Volltextzugriff (PDF)

Hypertension and accelerated atherosclerosis in endstage renal disease

Journal of nephrology, 1998-07, Vol.11 (4), p.185-195

1998

Volltextzugriff (PDF)

High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure

Kidney international, 1995-10, Vol.48 (4), p.1316-1323

1995

Volltextzugriff (PDF)

Treatment of Severe Thallium Intoxication

Clinical toxicology (Philadelphia, Pa.), 1997, Vol.35 (1), p.97-100

1997

Volltextzugriff (PDF)

Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment

American journal of nephrology, 1992, Vol.12 (3), p.188

1992

Volltextzugriff (PDF)

Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients

Nephron (2015), 1997, Vol.77 (4), p.484

1997

Volltextzugriff (PDF)

Portal vein thrombosis complicating peritonitis in a patient on chronic ambulatory peritoneal dialysis

Peritoneal dialysis international, 1994-01, Vol.14 (3), p.282

1994

Volltextzugriff (PDF)

1 – 25 von 518

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(461)
Mit Volltextzugriff
(445)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(444)
Humans
(305)
Life Sciences & Biomedicine
(303)
Male
(155)
Female
(151)
Middle Aged
(109)
Aged
(92)
Technology
(92)
Adult
(82)
Computer Science
(78)
Life Sciences
(76)
Biochemistry & Molecular Biology
(65)
Biochemistry, Biophysics & Molecular Biology
(59)
Biochimie, Biophysique & Biologie Moléculaire
(59)
Sciences Du Vivant
(59)
Multidisciplinary Sciences
(58)
Science & Technology - Other Topics
(58)
Biological And Medical Sciences
(57)
Computer Science, Theory & Methods
(52)
Genomes
(50)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Editorial: Rising stars in drugs outcomes research and policies: 2021

Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

A randomized n-of-1 study comparing blood pressure measured on a clothed arm and on an arm with a rolled-up sleeve

Outcome of Acute Kidney Injury with Different Treatment Options: Long-Term Follow-up

Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury

RRT treatment for AKI: is more always better?

Economic evaluation of different treatment modalities in acute kidney injury

Severity scoring and mortality 1 year after acute renal failure

Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

P-624: Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

P-204: Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients

Problems in the development, validation and adaptation of prognostic models for acute renal failure

Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study

Treating Hypertensive Patients With Intracranial Pathology

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study

Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at 1-receptor blocker in hypertensive patients

Changes in plasma renin match the antihypertensive effects of aliskiren in patients with hypertension: Placebo/irbesartan-controlled trial with the orally active renin inhibitor aliskiren

Hypertension and accelerated atherosclerosis in endstage renal disease

High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure

Treatment of Severe Thallium Intoxication

Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment

Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients

Portal vein thrombosis complicating peritonitis in a patient on chronic ambulatory peritoneal dialysis

Suchergebnisse filtern